Shared Care AgreementShared Care Agreement • March 27th, 2018Contract TypeShared Care AgreementFiledMarch 27th, 2018(Note: denosumab is licensed for use in men with cancer of the prostate who develop osteoporosis on hormone ablation therapy).
(Note: denosumab is licensed for use in men with cancer of the prostate who develop osteoporosis on hormone ablation therapy).